Results 221 to 230 of about 1,087,727 (251)
Some of the next articles are maybe not open access.
Minor histocompatibility antigens: past, present, and future
Tissue Antigens, 2014AbstractMinor histocompatibility (H) antigens are key molecules driving allo‐immune responses in both graft‐versus‐host‐disease (GvHD) and in graft‐versus‐leukemia (GvL) reactivity in human leukocyte antigen (HLA)‐matched hematopoietic stem‐cell transplantation (HSCT).
openaire +2 more sources
Minor Histocompatibility Antigens
The Cancer Journal, 2004Minor histocompatibility antigens have to be considered as key molecules in the stem cell-based immunotherapy of malignancies. Allogeneic stem cell transplantation (SCT) is a well-established and effective therapy for advanced hematologic malignancies.
openaire +2 more sources
Molecular Typing Methods for Minor Histocompatibility Antigens
2013Minor histocompatibility (H) antigen mismatching leads to clinically relevant alloimmune reactivity. Depending on the tissue expression pattern of the involved minor H antigens, the immune response may either cause graft-versus-host disease and a graft-versus-tumor effect or lead to only a graft-versus-leukemia effect. Thus, identification of recipient-
openaire +2 more sources
IMMUNE RESPONSE TO MINOR HISTOCOMPATIBILITY ANTIGENS
Transplantation, 1972L W, Schierman, R A, McBride
openaire +2 more sources
The Minor Histocompatibility Antigen HA-1: A Diallelic Gene with a Single Amino Acid Polymorphism
Science, 1998Víctor Engelhard +2 more
exaly
H-Y as a minor histocompatibility antigen in kidney transplantation: a retrospective cohort study
Lancet, The, 2008Alois Gratwohl, Bernd Döhler
exaly